510(k) K060452
K060452 is an FDA 510(k) premarket notification submitted by Neo-Genesis for the device "ACCUWELL 17-ALPHA-HYDROXYPROESTERONE ENZYME IMMUNOASSAY WITH MODELS 6015XX-ECAH". The FDA issued a decision of Substantially Equivalent on March 13, 2007. The device falls under product code JLX (Radioimmunoassay, 17-Hydroxyprogesterone), a Class I device regulated under 21 CFR 862.1395.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 13, 2007
- Date Received
- February 21, 2006
- Clearance Type
- Abbreviated
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, 17-Hydroxyprogesterone
- Device Class
- Class I
- Regulation Number
- 862.1395
- Review Panel
- CH
- Submission Type